{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:37:07Z","timestamp":1793277427088,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972832"],"award-info":[{"award-number":["81972832"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jcis.2024.01.066","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T21:31:36Z","timestamp":1705440696000},"page":"257-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis"],"prefix":"10.1016","volume":"660","author":[{"given":"Rui-Rui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Wu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcis.2024.01.066_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyx180","article-title":"Chemotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"48","author":"Ikeda","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jcis.2024.01.066_b0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopha.2018.02.108","article-title":"Chemotherapeutic agents for the treatment of metastatic breast cancer: an update","volume":"101","author":"Abotaleb","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jcis.2024.01.066_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640392","article-title":"Molecular mechanisms of chemotherapy resistance in head and neck cancers","volume":"11","author":"Kanno","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2017.03.005","article-title":"Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma","volume":"67","author":"Huang","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0030","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jcis.2024.01.066_b0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.jcis.2024.01.066_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jcis.2024.01.066_b0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"4","key":"10.1016\/j.jcis.2024.01.066_b0055","doi-asserted-by":"crossref","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","article-title":"The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents","volume":"2","author":"Yu","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.jcis.2024.01.066_b0060","doi-asserted-by":"crossref","unstructured":"J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T.F. Greten, P.R. Galle, J.F. Seitz, I. Borbath, D. Haussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, J. Bruix, S.I.S. Group, Sorafenib in advanced hepatocellular carcinoma, N. Engl. J. Med. 359 (4) (2008) 378\u201390.","DOI":"10.1056\/NEJMoa0708857"},{"issue":"11","key":"10.1016\/j.jcis.2024.01.066_b0065","first-page":"6417","article-title":"Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors","volume":"34","author":"Lachaier","year":"2014","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.jcis.2024.01.066_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.jcis.2024.01.066_b0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28574","article-title":"Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis","volume":"64","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcis.2024.01.066_b0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1634\/theoncologist.2008-0191","article-title":"Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis","volume":"14","author":"Pinter","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jcis.2024.01.066_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.jcis.2024.01.066_b0095","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/tox.22769","article-title":"Ursolic acid induces apoptosis and autophagy in oral cancer cells","volume":"34","author":"Lin","year":"2019","journal-title":"Environ. Toxicol."},{"issue":"5","key":"10.1016\/j.jcis.2024.01.066_b0100","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3892\/or.2015.4213","article-title":"Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition","volume":"34","author":"Zhang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.jcis.2024.01.066_b0105","first-page":"3274","article-title":"Ursolic acid suppresses the invasive potential of colorectal cancer cells by regulating the TGF-beta1\/ZEB1\/miR-200c signaling pathway","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"27","key":"10.1016\/j.jcis.2024.01.066_b0110","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1039\/C7NR01677H","article-title":"A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53\/MMP-9\/PTEN\/CD44 mediated multiple signaling pathways","volume":"9","author":"Jiang","year":"2017","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.jcis.2024.01.066_b0115","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.etap.2014.03.011","article-title":"Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK\/NF-kappa B pathway","volume":"37","author":"Ma","year":"2014","journal-title":"Environ. Toxicol. Phar."},{"issue":"18","key":"10.1016\/j.jcis.2024.01.066_b0120","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1158\/1078-0432.CCR-11-2805","article-title":"Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine","volume":"18","author":"Prasad","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jcis.2024.01.066_b0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cas.13425","article-title":"Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0130","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/ptr.6669","article-title":"Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells","volume":"34","author":"Lin","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jcis.2024.01.066_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106306","article-title":"Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer","volume":"182","author":"Li","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jcis.2024.01.066_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.030","article-title":"Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex","volume":"143","author":"Zhao","year":"2017","journal-title":"Biomaterials"},{"issue":"40","key":"10.1016\/j.jcis.2024.01.066_b0145","doi-asserted-by":"crossref","first-page":"14021","DOI":"10.1021\/jacs.7b08303","article-title":"A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy","volume":"139","author":"Wang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jcis.2024.01.066_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2018.12.007","article-title":"Near-infrared AIEgens as transformers to enhance tumor treatment efficacy with controllable self-assembled redox-responsive carrier-free nanodrug","volume":"193","author":"Zhang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcis.2024.01.066_b0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jconrel.2018.11.032","article-title":"Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy","volume":"294","author":"Shim","year":"2019","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jcis.2024.01.066_b0160","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1039\/C9NR10735E","article-title":"A self-assembled carrier-free nanosonosensitizer for photoacoustic imaging-guided synergistic chemo-sonodynamic cancer therapy","volume":"12","author":"Dong","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jcis.2024.01.066_b0165","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acsnano.0c10045","article-title":"Carrier-free hybrid DNA nanoparticles for light-induced self-delivery of functional nucleic acid enzymes","volume":"15","author":"Shi","year":"2021","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.jcis.2024.01.066_b0170","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acsnano.8b05860","article-title":"Ferrous-supply-regeneration nanoengineering for cancer-cell-specific ferroptosis in combination with imaging-guided photodynamic therapy","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.jcis.2024.01.066_b0175","doi-asserted-by":"crossref","first-page":"27856","DOI":"10.1021\/acsami.1c04868","article-title":"Self-assembling porphyrins as a single therapeutic agent for synergistic cancer therapy: a one stone three birds strategy","volume":"13","author":"Chen","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"26","key":"10.1016\/j.jcis.2024.01.066_b0180","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1039\/D0TB00850H","article-title":"Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance\/photoacoustic\/fluorescence imaging-guided synergistic photo-chemotherapy","volume":"8","author":"Tu","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jcis.2024.01.066_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120457","article-title":"A redox-triggered C-centered free radicals nanogenerator for self-enhanced magnetic resonance imaging and chemodynamic therapy","volume":"266","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jcis.2024.01.066_b0190","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1021\/acsnano.9b04181","article-title":"Co-delivery of bee venom Melittin and a photosensitizer with an organic-inorganic hybrid nanocarrier for photodynamic therapy and immunotherapy","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jcis.2024.01.066_b0195","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000301","article-title":"EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1","volume":"8","author":"Park","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.jcis.2024.01.066_b0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022830118","article-title":"Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown","volume":"118","author":"Zhang","year":"2021","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0205","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/acs.analchem.2c00023","article-title":"Acid-triggered H(2)O(2) self-supplying nanoplatform for (19)F-MRI with enhanced chemo-chemodynamic therapy","volume":"94","author":"Zhang","year":"2022","journal-title":"Anal. Chem."},{"issue":"15","key":"10.1016\/j.jcis.2024.01.066_b0210","doi-asserted-by":"crossref","DOI":"10.1063\/5.0005188","article-title":"Recent developments in the general atomic and molecular electronic structure system","volume":"152","author":"Barca","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron-density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"issue":"4","key":"10.1016\/j.jcis.2024.01.066_b0220","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1063\/1.455064","article-title":"A complete basis set model chemistry. I. The total energies of closed-shell atoms and hydrides of the first-row elements","volume":"89","author":"Petersson","year":"1988","journal-title":"J. Chem. Phys."},{"issue":"13","key":"10.1016\/j.jcis.2024.01.066_b0225","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jcc.21224","article-title":"PACKMOL: a package for building initial configurations for molecular dynamics simulations","volume":"30","author":"Mart\u00ednez","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.jcis.2024.01.066_b0230","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.jcis.2024.01.066_b0235","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0240","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.jcis.2024.01.066_b0245","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/acs.jctc.0c01320","article-title":"Parametrization of trivalent and tetravalent metal ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models","volume":"17","author":"Li","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jcis.2024.01.066_b0250","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1021\/j100384a009","article-title":"Ion-water interaction potentials derived from free energy perturbation simulations","volume":"94","author":"\u00c5qvist","year":"1990","journal-title":"J. Phys. Chem."},{"issue":"24","key":"10.1016\/j.jcis.2024.01.066_b0255","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1063\/1.1324708","article-title":"Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions","volume":"113","author":"Toukmaji","year":"2000","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.jcis.2024.01.066_b0260","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev. A Gen. Phys."},{"issue":"23","key":"10.1016\/j.jcis.2024.01.066_b0265","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1063\/1.469927","article-title":"Computer simulation of liquid\/liquid interfaces. I. Theory and application to octane\/water","volume":"103","author":"Zhang","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jcis.2024.01.066_b0270","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejmech.2019.01.070","article-title":"Excellent antitumor and antimetastatic activities based on novel coumarin\/pyrazole oxime hybrids","volume":"166","author":"Dai","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jcis.2024.01.066_b0275","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2017.12.061","article-title":"Development of novel beta-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells","volume":"144","author":"Ling","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0280","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12248-013-9559-2","article-title":"Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486)","volume":"16","author":"Wang","year":"2014","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.jcis.2024.01.066_b0285","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1359-6446(03)02988-X","article-title":"Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress","volume":"9","author":"Marcucci","year":"2004","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2009.10.020","article-title":"Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor","volume":"142","author":"Abu Lila","year":"2010","journal-title":"J. Control. Release"},{"issue":"50","key":"10.1016\/j.jcis.2024.01.066_b0295","doi-asserted-by":"crossref","first-page":"43508","DOI":"10.1021\/acsami.7b14755","article-title":"A small molecule nanodrug by self-Assembly of dual anticancer drugs and photosensitizer for synergistic near-Infrared cancer theranostics","volume":"9","author":"Guo","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.jcis.2024.01.066_b0300","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/anie.201509810","article-title":"Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy","volume":"55","author":"Liu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jcis.2024.01.066_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00671","article-title":"Colorimetric detection of salicylic acid in aspirin using MIL-53(Fe) nanozyme","volume":"8","author":"Liang","year":"2020","journal-title":"Front. Chem."},{"issue":"38","key":"10.1016\/j.jcis.2024.01.066_b0310","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1039\/c3tb20855a","article-title":"Blood compatibility of a new zwitterionic bare metal stent with hyperbranched polymer brushes","volume":"1","author":"Wang","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jcis.2024.01.066_b0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.colsurfb.2015.12.012","article-title":"Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers","volume":"139","author":"Lu","year":"2016","journal-title":"Colloids Surf. B"},{"issue":"10","key":"10.1016\/j.jcis.2024.01.066_b0320","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1535-7163.MCT-12-0093","article-title":"Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo","volume":"11","author":"Coriat","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0325","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jcis.2024.01.066_b0330","article-title":"The roles of ROS in cancer heterogeneity and therapy","volume":"2017","author":"de Sa","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jcis.2024.01.066_b0335","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphar.2017.00992","article-title":"The role of ferroptosis in cancer development and treatment response","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"1\u20132","key":"10.1016\/j.jcis.2024.01.066_b0345","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jcis.2024.01.066_b0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2017.12.026","article-title":"Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin","volume":"271","author":"Jiang","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jcis.2024.01.066_b0355","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"8","key":"10.1016\/j.jcis.2024.01.066_b0360","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"19","key":"10.1016\/j.jcis.2024.01.066_b0365","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.7150\/thno.62984","article-title":"Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jcis.2024.01.066_b0370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.056","article-title":"Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide","volume":"193","author":"He","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2024.01.066_b0375","doi-asserted-by":"crossref","first-page":"53634","DOI":"10.1021\/acsami.0c14046","article-title":"Tumor microenvironment-responsive Fe(III)-porphyrin nanotheranostics for tumor imaging and targeted chemodynamic-photodynamic therapy","author":"Wang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jcis.2024.01.066_bib378","doi-asserted-by":"crossref","first-page":"113724","DOI":"10.1016\/j.colsurfb.2023.113724","article-title":"Synergistic anti-tumor effect of dual drug co-assembled nanoparticles based on ursolic acid and sorafenib","volume":"234","author":"Tong","year":"2023","journal-title":"Colloids Surf. B, Biointerfaces"},{"key":"10.1016\/j.jcis.2024.01.066_bib379","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcis.2023.11.109","article-title":"Dual-drug controllable co-assembly nanosystem for targeted and synergistic treatment of hepatocellular carcinoma","volume":"656","author":"Le","year":"2024","journal-title":"J. Colloid Interface Sci."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979724000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979724000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:54:10Z","timestamp":1762196050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979724000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":77,"alternative-id":["S0021979724000742"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2024.01.066","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2024.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}